Abstract

Despite the proven usefulness of cyproterone acetate in therapy for priapism, credible concerns arise over its effects on patients as scientific literature correlates it to development..

Highlights

  • Despite the proven usefulness of cyproterone acetate in therapy for priapism, credible concerns arise over its effects on patients as scientific literature correlates it to development of meningioma

  • The research reported that the skull base predominance of meningioma associated with cyproterone acetate is highly notable according to this research

  • Women are the common meningioma patients but, men are the greatest sufferers of grades II and III meningioma

Read more

Summary

Introduction

Despite the proven usefulness of cyproterone acetate in therapy for priapism, credible concerns arise over its effects on patients as scientific literature correlates it to development of meningioma. Meningioma is a tumor of the primary central nervous system (CNS). This implies that cyproterone acetate is likened to causing meningioma, which begins either in the spinal cord or the brain. Meningiomas are the commonest type of primary brain tumor. This means that administration of cyproterone acetate in this therapy predisposes sickle cell patients to the ordinary meningioma or high grade meningiomas

Findings
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.